 |
|
Advance Directives and the Cost of Terminal Hospitalization
William B. Weeks, MD;
Lial L. Kofoed, MD;
Amy E. Wallace, MD;
H. Gilbert Welch, MD, MPH
Arch Intern Med. 1994;154(18):2077-2083.
Abstract
| |
Background
It has been assumed that patients using advance directives would direct terminal care away from the intensive care unit and choose shorter, less costly, less technological terminal hospital stays.
Methods
This retrospective cohort study examined 336 consecutive patients who died in a university tertiary care medical center: 242 without advance directives, 66 with a previously completed advance directive, 13 admitted for the express purpose of terminal care, and 15 who signed an advance directive during their terminal hospitalization. Total charges (hospital and physician) were calculated for all patients and were adjusted using both physician and hospital diagnosis-related group weights. Patient participation in end-of-life decisions was determined by chart review.
Results
The group without advance directives had dramatically higher mean total ($49 900 vs $31 200) terminal hospitalization charges than the group with previously completed advance directives, producing a charge ratio of 1.6. After diagnosis-related group adjustment, the charge ratio was 1.35 (95% confidence interval, 1.07 to 1.72) for physician charge, 1.36 (95% confidence interval, 1.06 to 1.74) for hospital charge, and 1.35 (95% confidence interval, 1.08 to 1.73) for total charge. Multiple regression analysis controlling for age, sex, and cancer diagnosis confirmed these findings. Patients with advance directives were significantly more likely to limit treatment and to participate in end-of-life decisions.
Conclusion
Patients without advance directives have significantly higher terminal hospitalization charges than those with advance directives. Our investigation suggests that the preferences of patients with advance directives are to limit care and these preferences influence the cost of terminal hospitalization.
(Arch Intern Med. 1994;154:2077-2083)
Author Affiliations
From the Department of Medicine, Veterans Affairs Medical Center, White River Junction, Vt (Drs Weeks, Wallace, and Welch) and the Departments of Psychiatry (Drs Weeks and Wallace) and the Center for the Evaluative Clinical Sciences (Dr Welch), Dartmouth Medical School, Hanover, NH; and the Department of Medicine, Veterans Affairs Medical Center and the Department of Psychiatry, University of South Dakota Medical School, Sioux Falls (Dr Kofoed).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Patients Who Complete Advance Directives and What They Prefer
Nishimura et al.
Mayo Clin Proc. 2007;82:1480-1486.
ABSTRACT
| FULL TEXT
The State of Advance Care Planning: One Decade After SUPPORT
Collins et al.
AM J HOSP PALLIAT CARE 2006;23:378-384.
ABSTRACT
Brief Communication: The Relationship between Having a Living Will and Dying in Place
Degenholtz et al.
ANN INTERN MED 2004;141:113-117.
ABSTRACT
| FULL TEXT
Advance Directives for Nursing Home Residents: Achieving Compassionate, Competent, Cost-effective Care
Teno
JAMA 2000;283:1481-1482.
FULL TEXT
Lessons learned and not learned from the SUPPORT project
Teno
Palliat Med 1999;13:91-93.
Death and End-of-Life Planning in One Midwestern Community
Hammes and Rooney
Arch Intern Med 1998;158:383-390.
ABSTRACT
| FULL TEXT
Cost Savings at the End of Life: What Do the Data Show?
Emanuel
JAMA 1996;275:1907-1914.
ABSTRACT
Advance End-of-Life Treatment Planning
Miles et al.
Arch Intern Med 1996;156:1062-1068.
ABSTRACT
The Use of Living Wills at the End of Life: A National Study
Hanson and Rodgman
Arch Intern Med 1996;156:1018-1022.
ABSTRACT
|
